Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Frank Bennett

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
Science Translational Medicine|March 4, 2011
Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophyMarco A Passini, Jie Bu, Amy M Richards, et al.
Human Molecular Genetics|April 21, 2009
Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotidesLoren G Fong, Timothy A Vickers, Emily A Farber, et al.
Nature Medicine|October 13, 2021
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trialMan-Fung Yuen, Jeong Heo, Jeong-Won Jang, et al.
Plos One|April 29, 2017
Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's diseaseSydney R Coffey, Robert M Bragg, Shawn Minnig, et al.
Cell Metabolism|February 7, 2006
miR-122 regulation of lipid metabolism revealed by in vivo antisense targetingChristine Esau, Scott Davis, Susan F Murray, et al.
Nature Neuroscience|March 2, 2011
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43Magdalini Polymenidou, Clotilde Lagier-Tourenne, Kasey R Hutt, et al.
The Journal of Clinical Investigation|March 3, 2006
Prelamin A and lamin A appear to be dispensable in the nuclear laminaLoren G Fong, Jennifer K Ng, Jan Lammerding, et al.
Journal of Medicinal Chemistry|April 28, 2010
Peptide nucleic acids conjugated to short basic peptides show improved pharmacokinetics and antisense activity in adipose tissueEdward V Wancewicz, Martin A Maier, Andrew M Siwkowski, et al.
Plos One|September 11, 2014
Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patientsNiels H Skotte, Amber L Southwell, Michael E Østergaard, et al.
Journal of Medicinal Chemistry|October 14, 2005
Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acidKlaus Albertshofer, Andrew M Siwkowski, Edward V Wancewicz, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Science Translational Medicine|March 4, 2011
Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophyMarco A Passini, Jie Bu, Amy M Richards, et al.
Human Molecular Genetics|April 21, 2009
Activating the synthesis of progerin, the mutant prelamin A in Hutchinson-Gilford progeria syndrome, with antisense oligonucleotidesLoren G Fong, Timothy A Vickers, Emily A Farber, et al.
Nature Medicine|October 13, 2021
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trialMan-Fung Yuen, Jeong Heo, Jeong-Won Jang, et al.
Plos One|April 29, 2017
Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington's diseaseSydney R Coffey, Robert M Bragg, Shawn Minnig, et al.
Cell Metabolism|February 7, 2006
miR-122 regulation of lipid metabolism revealed by in vivo antisense targetingChristine Esau, Scott Davis, Susan F Murray, et al.
Nature Neuroscience|March 2, 2011
Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43Magdalini Polymenidou, Clotilde Lagier-Tourenne, Kasey R Hutt, et al.
The Journal of Clinical Investigation|March 3, 2006
Prelamin A and lamin A appear to be dispensable in the nuclear laminaLoren G Fong, Jennifer K Ng, Jan Lammerding, et al.
Journal of Medicinal Chemistry|April 28, 2010
Peptide nucleic acids conjugated to short basic peptides show improved pharmacokinetics and antisense activity in adipose tissueEdward V Wancewicz, Martin A Maier, Andrew M Siwkowski, et al.
Plos One|September 11, 2014
Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patientsNiels H Skotte, Amber L Southwell, Michael E Østergaard, et al.
Journal of Medicinal Chemistry|October 14, 2005
Structure-activity relationship study on a simple cationic peptide motif for cellular delivery of antisense peptide nucleic acidKlaus Albertshofer, Andrew M Siwkowski, Edward V Wancewicz, et al.
Pageof 17